Latest Stories

Latest Stories

Pages

X-Box: not quite so live

| Oct 24, 2005
Today Microsoft has intentionally shut down its wildly popular X-Box Live online video gaming site. Rachel Dornhelm tells us why.

Earnings report card

Stacey Vanek Smith | Oct 24, 2005
The earnings season is more than half way through, but already the lessons of the third quarter are clear. Stacey Vanek-Smith reports.
Posted In: Wall Street

Aflatoxin hits corn crops

| Oct 24, 2005
A toxic fungal residue has affected 30% of the corn crop in some Midwestern states — an aftereffect from this summer's drought. Janet Babin reports.

Listener Letters for October 21, 2005

| Oct 22, 2005
Time for us to peek into the <em>Marketplace Money</em> letters bag. Don't miss the missives.

The "Buzzword": Legacy Costs

| Oct 22, 2005
Life is hard enough without having to decipher everything. Each week, <em>Marketplace Money</em> brings you a word or a phrase that has bubbled to the top of the news. For instance &mdash; "Legacy Costs." You hear it, you see it, but do you really know it?

The Mailbag for October 21, 2005

| Oct 21, 2005
Our economics editor Chris Farrell answers more of your burning money questions. This week: advice on renting a property, starting a retirement account, and combining a home equity loan with mortgage.
Posted In: Housing, Retirement

The "Straight Story" with Chris Farrell: Not for Sale

| Oct 21, 2005
It's time once again for economics editor Chris Farrell to help you sort out the "Straight Story." This week, Chris gives a standing ovation to some representation on taxation.
Posted In: Taxes

From the Money Matters Desk: Pre-Paid Tuition Plans

| Oct 21, 2005
On this week's Money Matters &mdash; our regular look at how to improve your bottom line &mdash; we look at the pre-paid tuition plans that many states offer. Can they take the bite of the bill for college? Joining Kai is Professor Sandy Baum, an analyst for the College Board.
Posted In: Investing

Good as Gold?

| Oct 21, 2005
Gold has staged a glittering comeback. With prices soaring, is now the right time to gild your portfolio? Personal Finance writer Terry Savage offers her take.
Posted In: Investing

Buying Bio Tech

| Oct 21, 2005
Health officials want Swiss pharmaceutical giant Roche to let other companies to make its anti-viral medicine, Tamiflu. More than 40 countries have stockpiled that drug to help against a possible bird-flu outbreak. With countries gobbling up medicine, should investors be gobbling up stock in pharmaceutical companies? Harvard Business Professor Debora Spar separates the fact from the fiction.
Posted In: Investing

Pages